Business
Euronext Growth - Schedule One
Euronext Growth - Schedule One.
About this update from Hvivo Plc
[{"type":"text","content":"\n \nRNS Number : 3489C Venn Life Sciences Holdings PLC 14 June 2019 \n\nPre-Admission Announcement\nEuronext Growth Schedule 1\n\n\n\n\nAnnouncement to be made by the Euronext Growth Applicant prior to admission in accordance with rule 2 of the Euronext Growth Rules for Companies\n\n\n\n\n\nAll Applicants must complete the following\n\n\n\n\n\nCompany name \nVenn Life Sciences Holdings plc\n\n\n \n\n\n\n\nCompany registered address and if different, company trading address (including postcodes)\n\n\n\n\n \nRegistered Office:\n \nPO Box W1J 6BD, Berkley Square House, 2nd Floor, Mayfair, London, W1J 8DJ\n \nTrading Office:\n \n19 Railway Road, Dalkey, Dublin, Ireland\n \n\n\n\n\nCountry of incorporation \n\n\nEngland and Wales\n\n\n\n\nCompany website address containing all information required by rule 26 in the Euronext Growth Rules for Companies\n\n\n\n\n \nwww.vennlifesciences.com/ and with effect from Admission, www.openorphan.com \n\n\n\n\nCompany business (including main country of operation) or, in the case of an investing company, details of its investing strategy. If the admission is sought as a result of a reverse takeover under rule 14 of the Euronext Growth Rules for Companies, this should be stated\n \nThis is a reverse takeover under Rule 14.\n \nOpen Orphan is Clinical Research Organisation that specialises in rare and orphan drugs. The headquarters are in Dublin, Ireland and the company also has offices in France, the Netherlands and Germany. \n\n\n\n\n \n\n\n\n\nDetails of securities to be admitted including any restrictions as to transfer of securities (i.e. where known, number of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):\n \nNumber of ordinary shares of 0.01 pence each in nominal value (\"Ordinary Shares\") for which Admission will be sought: 253,493,259\n \nPlacing price per Ordinary Share: 5.6 pence\n \nThe are no restrictions as to the transferability of the Ordinary Shares and no Ordinary Shares will be held in treasury.\n\n\n\n\n \n\n\n\n \n \n \n\n\n\n \n\n\n\n\nCapital to be raised on admission (if applicable) and anticipated market capitalisation on admission:\n \nCapital to be raised on admissio...